Getinge AB Adjusts Valuation Metrics Amidst Complex Financial Landscape

Getinge AB, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a notable shift in its valuation metrics, indicating a more complex financial landscape for the company. The stock's P/E ratio stands at 20, while the Price to Book Value is recorded at 1.75. Additionally, Getinge AB's EV to EBIT is 12.67, and its EV to EBITDA is 8.67, showcasing its operational efficiency. The company also maintains a PEG ratio of 1.42, which suggests a balanced growth perspective relative to its earnings. In terms of returns, Getinge AB has achieved a return of 1.59% over the past year, with profits increasing by 14.2%. The dividend yield is noted at 2.26%, and the company has demonstrated a strong ROCE of 12.78%. Furthermore, the inventory turnover ratio has reached a high of 3.09 times, reflecting effective inventory management. Overall, Getinge AB continues to be recognized among the top 1% of companies rated by MarketsMojo, highlighting its competitive position within the industry. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.